Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:574

Hepatitis A Global Clinical Trials Review, Q2, 2011

Hepatitis A Global Clinical Trials Review, Q2, 2011

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $1,000.00
Meta Description Hepatitis A Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Hepatitis A Global Clinical
Publisher GlobalData
Date of Report Jun 15, 2011
Quick Overview
Hepatitis A Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Hepatitis A Global Clinical Trials Review, Q2, 2011" provides data on the Hepatitis A clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis A. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis A. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Hepatitis A 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Hepatitis A 19
Subjects Recruited Over a Period of Time 20
Prominent Sponsors 21
Top Companies Participating in Hepatitis A Therapeutics Clinical Trials 23
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
GlaxoSmithKline plc 26
Clinical Trial Overview of GlaxoSmithKline plc 26
Sanofi 28
Clinical Trial Overview of Sanofi 28
Merck & Co., Inc. 29
Clinical Trial Overview of Merck & Co., Inc. 29
Crucell Switzerland AG 30
Clinical Trial Overview of Crucell Switzerland AG 30
Sinovac Biotech Co., Ltd. 31
Clinical Trial Overview of Sinovac Biotech Co., Ltd. 31
Berna Products Corp. 32
Clinical Trial Overview of Berna Products Corp. 32
Crucell Holland B.V 33
Clinical Trial Overview of Crucell Holland B.V 33
Clinical Trial Overview of Top Universities / Institutes / Hospitals 34
Centers for Disease Control and Prevention 34
Clinical Trial Overview of Centers for Disease Control and Prevention 34
Sormland County Council 35
Clinical Trial Overview of Sormland County Council 35
University of Maryland School of Medicine 36
Clinical Trial Overview of University of Maryland School of Medicine 36
Council of Scientific and Industrial Research 37
Clinical Trial Overview of Council of Scientific and Industrial Research 37
University of Sao Paulo General Hospital 38
Clinical Trial Overview of University of Sao Paulo General Hospital 38
Asan Medical Center 39
Clinical Trial Overview of Asan Medical Center 39
University of Geneva 40
Clinical Trial Overview of University of Geneva 40
Rijnstate Hospital 41
Clinical Trial Overview of Rijnstate Hospital 41
Aalborg Hospital 42
Clinical Trial Overview of Aalborg Hospital 42
Appendix 43
Abbreviations 43
Definitions 43
Research Methodology 44
Secondary Research 44
About GlobalData 45
Contact Us 45
Disclaimer 45
Source 45




...